Fluorescence Imaging System
Surgical Guidance in Oncology (e.g., Breast, Prostate Cancer)
Key Facts
About OnLume
OnLume is pioneering intraoperative fluorescence imaging to enhance the precision and outcomes of cancer surgeries. The company's core platform integrates specialized imaging hardware with targeted fluorescent agents to provide surgeons with real-time, high-contrast visualization of tumors and critical anatomy. Operating in the competitive but high-growth surgical guidance market, OnLume targets the significant unmet need for improved margin assessment and nerve sparing in procedures like breast cancer and prostatectomies. As a private, likely pre-revenue entity, its success hinges on clinical validation, regulatory clearance, and commercial execution in a capital-intensive medical device sector.
View full company profile